Neonatal purpura fulminans secondary to group B streptococcal infection

Pediatric Hematology and Oncology

Volumn 27, Issue 8, 2010, Pages 620-625

  Zenciroglu, Aysegul ^a   Karagol, Belma Saygili ^a   Ipek, Mehmet Sah ^a   Okumus, Nurullah ^a   Yarali, Nese ^a   Aydin, Mustafa ^a  

^a Childrens' Education and Research Hospital   (Turkey)

Author keywords

Group B Streptococcus; Neonate; Purpura fulminans; Septicemia; Thrombosis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; C REACTIVE PROTEIN; CEFOTAXIME; D DIMER; FIBRINOGEN; FRESH FROZEN PLASMA; INFUSION FLUID; INOTROPIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NETILMICIN; PROTEIN C; PROTEIN S; SODIUM CHLORIDE;

ACIDOSIS; ANTIBIOTIC THERAPY; ARM; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BACTERIUM ISOLATION; BETA HEMOLYTIC STREPTOCOCCUS; BLOOD GAS; BLOOD TRANSFUSION; BRAIN ISCHEMIA; CASE REPORT; CEREBRAL BLINDNESS; CONVULSION; CYANOSIS; ECCHYMOSIS; ELBOW; EMERGENCY WARD; ENCEPHALOMALACIA; EYE MOVEMENT DISORDER; FEVER; FIBRINOGEN BLOOD LEVEL; FINGER AMPUTATION; FOLLOW UP; FOOT; FOOT AMPUTATION; FULMINATING PURPURA; GROUP B STREPTOCOCCAL INFECTION; HAND; HAND AMPUTATION; HEMODYNAMIC PARAMETERS; HOSPITAL ADMISSION; HUMAN; HYPERCAPNIA; HYPOXIA; IRRITABILITY; KNEE; LEG; LEUKOPENIA; MALE; MATERNAL DISEASE; MONONEUROPATHY MULTIPLEX; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; PENICILLIN RESISTANCE; PHYSIOTHERAPY; PROTHROMBIN TIME; RESUSCITATION; SEPTICEMIA; SKIN DEFECT; SUBARACHNOID HEMORRHAGE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION; VAGINA DISCHARGE; VAGINITIS;

ANTI-BACTERIAL AGENTS; FOLLOW-UP STUDIES; HEPARIN; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; NECROSIS; PURPURA FULMINANS; STREPTOCOCCAL INFECTIONS;

EID: 77958023178     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.503339     Document Type: Article

References (21)

1. Darmstadt GL. Acute infectious purpura fulminans: pathogenesis and medicalmanagement. Pediatr Dermatol. 1998;15:169-183.
2. Stewart FJ, McClure BG, Mayne E. Successful treatment of neonatal purpura fulminans with epoprostenol. J R Soc Med. 1991;84:623-624.
3. Lynn NJ, Pauly TH, Desai NS. Purpura fulminans in there cases of early-onset neonatal group B streptococcal meningitis. J Perinatol. 1991;11:144-146.
4. Atay E, Akin M, Yuzkoller E. Neonatal purpura fulminans associated with early-onset gram-negative enterobacter septicemia: a case report. Ind Pediatr. 2003;18:162-163.
5. Chu DZ, Blaisdell FW. Purpura fulminans. Am J Surg. 1982;143:356-362.
6. Gurses N, Ozkan A. Neonatal and childhood purpura fulminans: review of seven cases. Cutis. 1988;41:361-363.
7. Sen K, Roy A. Management of neonatal purpura fulminans with severe protein C deficiency. Indian Pediatr. 2006;43:542-545.
8. Ezer U, Misirlioglu ED, Colba V, et al. Neonatal purpura fulminans due to homozygous protein C deficiency. Pediatr Hematol Oncol. 2001;18:453-458.
9. Clegg HW, Todres ID, Moylan FM, et al. Fulminant neonatal meningococcemia. Am J Dis Child. 1980;134:354-355.
10. Manginello FP, Pascale JA, Wolfsdorf J, et al. Neonatal meningococcal meningitis and meningococcemia. Am J Dis Child. 1979;133:651-652.
11. Katier N, Traen M, Dooy JD, et al. Neonatal purpura due to Neisseria meningitidis serogroup C infection. Eur J Pediatr. 2003;162:283-284.
12. Hon KL, So KW, Wong W, et al. Spot diagnosis: an ominous rash in a newborn. Italian J Pediatr. 2009;35:10-12.
13. Gerson WT, Dickerman JD, Bovill EG, et al. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation:treatment with protein C concentrate. Pediatrics. 1993;91:418-422.
14. Alberio L, Lammle B, Esmon CT. Protein C replacement in severe meningococcemia: rationale and clinical experience. Clin Infect Dis. 2001;32:1338-1346.
15. Faust SN, Levin M, HarrisonOB. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345:408-416.
16. Kravitz GR, Dries DJ, Peterson ML, et al. Purpura fulminans due to staphylococcus aureus. CID. 2005;40:941-947.
17. Edlich RF, Cross CL, Dahlstrom JJ. Modern concepts of the diagnosis and treatment of purpura fulminans. J Environ Pathol Toxicol Oncol. 2008;27:191-196.
18. Erdeve O, Atasay B, Arsan S. Collagenase application for amputation in a preterm. Pediatr Dermatol. 2007;24:195-196.
19. Alyamac Dizdar E, Oguz S, Nur Sari F, et al. Enterocutaneous fistula secondary to purpura fulminans in a preterm infant. J Pediatr Hematol Oncol. 2009;31:753-755.
20. Schrag SJ, Zywicki S, Farley MM, et al. Group B sreptoccocal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20.
21. Schuchat A, Zywicki SS, Dinsmoor MJ. Risk factors and oppurtunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics. 2000;64:60-64.